Tracy Newbold
Chief Tech/Sci/R&D Officer at LEXICON PHARMACEUTICALS, INC.
Tracy Newbold active positions
Companies | Position | Start | End |
---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-06-30 | - |
Career history of Tracy Newbold
Former positions of Tracy Newbold
Companies | Position | Start | End |
---|---|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 2016-12-31 | 2019-12-31 |
UNITED THERAPEUTICS CORPORATION | Chief Operating Officer | 2010-12-31 | 2016-12-31 |
IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 2020-01-31 | - |
Training of Tracy Newbold
The University of North Carolina at Chapel Hill | Undergraduate Degree |
Statistics
International
United States | 5 |
Israel | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Chief Operating Officer | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
IMMUNOVANT, INC. | Health Technology |
UNITED THERAPEUTICS CORPORATION | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Tracy Newbold
- Experience